Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UPADACITINIB vs VALACYCLOVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

UPADACITINIB vs VALACYCLOVIR: Safety Overview

Metric UPADACITINIB VALACYCLOVIR
Total FAERS Reports 65,656 13,138
Deaths Reported 2,406 812
Death Rate 3.7% 6.2%
Hospitalizations 15,931 6,169
Average Patient Age 57.4 yrs 60.9 yrs
% Female Patients 71.2% 56.3%
FDA Approval Date Apr 26, 2024 Apr 3, 2012
Manufacturer AbbVie Inc. ST. MARY'S MEDICAL PARK PHARMACY
Route ORAL ORAL
Marketing Status Prescription Prescription